AlanCChuDO

Nephrology • New York, NY

Physician

Join to view full profile

Are you Dr. Chu?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Connect with colleagues in the same hospital or clinic
You already have 64 invites waiting!
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Office
217 Grand St
Suite 401
New York, NY 10013
Phone+1 212-965-1380

Fax+1 585-241-1265
Is this information wrong?

Summary

Dr. Alan Chu, DO is a nephrologist in New York, New York. He is currently licensed to practice medicine in New York, North Dakota, and New Jersey. He is affiliated with Geneva General Hospital.

Education & Training

Rutgers Health/Robert Wood Johnson Medical SchoolFellowship, Nephrology, 2006 - 2008
Rutgers Health/Robert Wood Johnson Medical SchoolResidency, Internal Medicine, 2004 - 2006
University of Southern California/LAC+USC Medical CenterInternship, Internal Medicine, 2003 - 2004
NYIT College Of Osteopathic MedicineClass of 2002

Certifications & Licensure

NY State License 2008 - 2025
NJ State License 2005 - 2015
ND State License 2009 - 2009
American Board of Internal Medicine Nephrology
National Board of Physicians and Surgeons Internal Medicine
National Board of Physicians and Surgeons Nephrology

Awards, Honors, & Recognition

Physician Practice Connections Recognition Program National Committee for Quality Assurance, 2012-2015
Patient-Centered Medical Home Recognition Program National Committee for Quality Assurance, 2012-2015
CMS Meaningful Use Stage 1 Certification MEDENT EMR/EHR, Community Computer Service, Inc., 2011

Publications & Presentations

PubMed

80 citations
FTY720: A Promising Agent for Treatment of Metastatic Hepatocellular Carcinoma
Terence K. Lee, Kwan Man, Joanna W. Ho, Xianghong Wang, Ronnie T.P. Poon, Yang Xu, Kevin Tak-Pan Ng, Alan C. Chu, Chris K. Sun, Irene Oi-Lin Ng, Hui-Chuan Sun, Zao You...> ;Clinical Cancer Research. 2005 Dec 1
Inhibition of P-glycoprotein expression and reversal of drug resistance of human hepatoma HepG2 cells by multidrug resistance gene (mdr1) antisense RNA.
Chan JY, Chu AC, Fung KP> ;Life Sci.. 2000-09-15
Low density lipoprotein as a targeted carrier for doxorubicin in nude mice bearing human hepatoma HepG2 cells.
Chu, A. C., Tsang, S. Y., Lo, E. H., Fung, K. P.> ;Life Sci. 2001 Dec 21
Neuromyelitis optica-IgG in idiopathic inflammatory demyelinating disorders amongst Hong Kong Chinese.
Chan, K. H., Ramsden, D. B., Yu, Y. L., Kwok, K. H., Chu, A. C., Ho, P. W., Kwan, J. S., Lee, R., Lim, E., Kung, M. H., Ho, S. L.> ;Eur J Neurol. 2009 Mar 01
Effects of plasticisers and related compounds on the expression of the soluble form of catechol-O-methyltransferase in MCF-7 cells.
Ho, P. W., Chu, A. C., Kwok, K. H., Liu, H. F., Kung, M. H., Ramsden, D. B., Ho, S. L.> ;Curr Drug Metab. 2008 May
Aquaporin-4 water channel expression by thymoma of patients with and without myasthenia gravis.
Chan, K. H., Kwan, J. S., Ho, P. W., Ho, S. L., Chui, W. H., Chu, A. C., Ho, J. W., Zhang, W. Y., Kung, M. H.> ;J Neuroimmunol. 2010 Oct 8
Clinical outcome of relapsing remitting multiple sclerosis among Hong Kong Chinese.
Chan, K. H., Tsang, K. L., Ho, P. W., Tse, C. T., Kwan, J. S., Ho, J. W., Chu, A. C., Chang, R. S., Ho, S. L.> ;Clin Neurol Neurosurg. 2011 Oct
Estrogenic phenol and catechol metabolites of PCBs modulate catechol-O-methyltransferase expression via the estrogen receptor: potential contribution to cancer risk.
Ho, P. W., Garner, C. E., Ho, J. W., Leung, K. C., Chu, A. C., Kwok, K. H., Kung, M. H., Burka, L. T., Ramsden, D. B., Ho, S. L.> ;Curr Drug Metab. 2008 May
Join now to see all

Hospital Affiliations

Geneva General HospitalGeneva, New York